Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7329 p840
11 December 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NPA outlines benefits of independent prescribing by pharmacists

Independent prescribing by pharmacists is on the agenda for 2005

Independent prescribing by pharmacists is on the agenda for 2005

Independent prescribing by community pharmacists will increase patient choice, access and equity, according to a position paper published this week by the National Pharmaceutical Association.

The Government is expected to issue a public consultation early next year on extending independent prescribing rights to pharmacists. This will follow discussions on the subject which are currently ongoing.

The NPA position paper will form the basis of the association’s response to the consultation. It outlines the benefits of independent prescribing by community pharmacists for patients, the NHS and the profession, and the issues that need to be addressed in order for independent prescribing to be taken forward.

Among the issues are how prescribing will be funded, whether or not prescribing should be restricted to a formulary, and clinical governance and probity issues.

Ash Soni, chairman of the NPA, commented: “The pharmacy profession is well placed to play a significant role in independent prescribing and community pharmacists have a particular contribution to make in increasing access and choice for treatment for minor ailments both during normal hours and out of hours.”

Back to Top


©The Pharmaceutical Journal